#antibiotic-stewardship

Patients receive antibiotics when not needed, or receive unnecessarily broad, long, or poorly selected treatment, increasing avoidable selection pressure and adverse effects.

Prioritize antibiotics with new targets or mechanisms against critical resistant pathogens and plan registration, manufacturing, supply and stewardship across income settings before approval.

Pay suppliers predictable amounts for the availability and public-health value of priority antibiotics rather than rewarding the number of doses sold.

Reduce routine antimicrobial demand by improving vaccination, hygiene, housing, stocking practices, nutrition, breeding and veterinary prevention in livestock and aquaculture.

Collect farm-level antimicrobial sales and use data by species, farm, and indication; normalize for animal populations; provide confidential benchmarking to farmers and vets; and require review and improvement plans for persistent high users.

Prohibit medically important antimicrobials for growth promotion and routine group prophylaxis while preserving supervised treatment for animals that are genuinely ill.

Coordinate registration, procurement, quality assurance, forecasting and supply so patients can obtain effective Access and Reserve antibiotics without promoting uncontrolled use.

Build affordable laboratory networks that identify bacterial pathogens and susceptibility patterns quickly enough to guide individual treatment and local resistance policies.

Increase coverage of existing vaccines (pneumococcal, Hib, influenza, rotavirus, typhoid) and develop new vaccines against high-burden bacterial pathogens to prevent resistant infections and cut antibiotic demand.

Combine hand hygiene, environmental cleaning, screening, isolation or cohorting, transfer alerts and central outbreak oversight to stop resistant bacteria spreading between patients and facilities.

Give selected low-risk patients a prescription to use only if symptoms persist or worsen, with clear safety-net instructions and rapid reassessment routes.

Integrate rapid pathogen or biomarker tests with clinical guidance, training and stewardship follow-up so results change antibiotic selection rather than merely add information.

Align treatment guidance, essential-medicine lists and purchasing with WHO Access, Watch and Reserve categories so first-line Access antibiotics are available and higher-risk products are controlled.

Create multidisciplinary stewardship teams that issue local treatment guidance, review prescribing, feed results back to clinicians and safely narrow or stop unnecessary antibiotics.

NHS England and NICE piloted fixed annual payments for access to cefiderocol and ceftazidime-avibactam, with value assessment designed to recognize preparedness and public-health benefits rather than prescription volume…

Beginning in 2009, the Netherlands combined national reduction targets with farm-level and veterinarian benchmarking, restrictions on critically important antibiotics, mandatory treatment plans and sector-specific anima…

China banned colistin as a growth-promoting feed additive in 2017 after plasmid-mediated mcr-1 resistance was identified in animals, food and people. Researchers compared colistin use, resistant Escherichia coli and mcr…

Denmark progressively ended antimicrobial growth promotion, beginning with specific products and followed by voluntary and regulatory withdrawal across major pig and poultry production. DANMAP (Danish Integrated Antimic…

The United States introduced pneumococcal conjugate vaccination (PCV7, later expanded to PCV13) for children in 2000. Vaccination reduced invasive pneumococcal disease caused by vaccine serotypes — many of which were an…

A clonal outbreak of carbapenem-resistant Klebsiella pneumoniae spread across Israeli hospitals during 2006 and was not controlled by local measures. In 2007 the Ministry of Health mandated physical separation of carrie…

A randomized trial across 16 general practices in southwest England tested whether rapid multiplex microbiological point-of-care testing would reduce same-day antibiotic prescribing for children and adults with respirat…

Forty-eight community health centres in Vietnam were randomized to routine care or routine care with point-of-care C-reactive protein (CRP) testing for patients with non-severe acute respiratory infections. Testing was…

After macrolide resistance in group A streptococci rose in Finland, national recommendations were issued by public-health authorities and clinical professional bodies to reduce macrolide use for respiratory and skin inf…

Sweden established Strama in 1995 as a national and regional collaboration for rational antibiotic use. Regional groups combine local treatment recommendations, surveillance, professional education, prescribing feedback…